Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
PLX compared with VNCE: revenue, margins and what each company keeps, and the suppliers and customers both name
PLX
Protalix BioTherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
VNCE
Vince Holding Corp.
Change
Mkt cap
Revenue
Revenue
vs
Compare
PLX
Protalix BioTherapeutics, Inc.
vs
VNCE
Vince Holding Corp.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
PLX
Protalix BioTherapeutics, Inc.
Change
2.60
▼
−0.57%
· post 2.60
Mkt cap
$208.7M
Revenue
$20M
Q2 FY26
Revenue
$53M
FY25
VNCE
Vince Holding Corp.
Change
10.64
▲
+0.42%
· post 10.66
Closed
Oct 30 '26
Mkt cap
$138.1M
Revenue
$82M
Q2 FY26
Revenue
$300M
FY25
vs
Compare
Closed
Oct 30 '26
PLX
Protalix BioTherapeutics, Inc.
vs
VNCE
Vince Holding Corp.
2.60
▼
−0.57%
post 2.60
Price
10.64
▲
+0.42%
post 10.66
$208.7M
Mkt cap
$138.1M
Q2 FY26
$20M
Revenue
$82M
Q2 FY26
FY25
$53M
Revenue
$300M
FY25
Change
Change
PLX
2.60
▼
−0.57%
vs
VNCE
10.64
▲
+0.42%
Closed
Oct 30 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
PLX, solid
VNCE, dashed